Navigation Links
Mirixa Corporation and the APhA Foundation Form Partnership
Date:10/9/2008

APhA Foundation and NCPA Join Forces to Deliver Patient Care via Single

Platform, MirixaPro(SM)

RESTON, Va. and WASHINGTON, Oct. 9 /PRNewswire/ -- Mirixa Corporation and the American Pharmacists Association (APhA) Foundation, the creator of the Diabetes Ten City Challenge and a partner in the Asheville Project(R), jointly announced today that they will form a new partnership that will deliver all of APhA Foundation's HealthMapRx commercial programs via Mirixa. MirixaPro(SM) will be the platform of choice for all existing and future APhA Foundation commercial programs delivered through pharmacy.

This partnership joins the quality and reach of Mirixa-enabled patient care programs and services with the APhA Foundation's highly respected and nationally renowned employer-based disease management and wellness research efforts. Additionally, this enhanced alliance between the National Community Pharmacist Association (NCPA), which sponsors Mirixa, and the APhA Foundation represents a significant opportunity for the pharmacy community by providing enhanced opportunities to deliver patient care services.

"We are delighted to have earned the trust of the APhA Foundation and to be selected as their business partner and pharmacy platform of choice," expressed Rick Solano, Mirixa's Chief Executive Officer. "This partnership represents a significant step forward in enhancing pharmacy-based patient care and education services at the national level, and will help pharmacists improve consumer health and the quality of many lives," added Mr. Solano.

"This important collaboration between national pharmacist organizations has the tremendous potential to incentivize wellness, improve patient outcomes and manage costs, thereby addressing critical issues facing the U.S. healthcare system. The new partnership creates synergies that will provide enhanced service delivery and program offerings to current and future clients and responds to requests by our employer clients and pharmacists for integrated systems for patient care," said William Ellis, R.Ph., Executive Director and Chief Executive Officer of the APhA Foundation.

Mirixa will manage the new partnership and will begin integration and transition steps as soon as the partnership is finalized. All existing commercialized APhA Foundation programs will continue uninterrupted during the transition period. The APhA Foundation will continue to focus on its core mission to improve the quality of consumer health outcomes through demonstration projects, incentive grants, institutes and scholarship programs.

About the APhA Foundation

The American Pharmacists Association (APhA) Foundation, headquartered in Washington, D.C., is a non-profit organization affiliated with the American Pharmacists Association, the national professional society of pharmacists in the United States. The APhA Foundation has expertise in designing programs that seek to create a new medication use system in the United States where patients, pharmacists, physicians and other health care providers collaborate to dramatically improve the cost and quality of consumer health outcomes through the safe and effective use of medications. For additional information: http://www.aphafoundation.org.

About Mirixa

Mirixa Corporation, sponsored by the National Community Pharmacists Association (NCPA), is the leader in targeted patient care services delivered via the nation's largest pharmacy-based patient care network. Dedicated to improving patients' health, Mirixa enables the healthcare community to deliver patient care services through retail pharmacy. Mirixa's web-based clinical application, MirixaPro(SM), is used by pharmacists to deliver standardized patient care services. For more information, please visit http://www.Mirixa.com.

Contacts: Christine Ryba Lisa Miller

703.865.2041 703.838.2682

PR@Mirixa.com Lisa.Miller@ncpanet.org


'/>"/>
SOURCE Mirixa Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
2. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
3. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
4. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
5. BioElectronics Corporation Announces Singapore and Malaysia Sales
6. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
7. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
8. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
9. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
10. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
11. Enova Medical Launches Exos Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... OXFORD, England , December 8, 2016 /PRNewswire/ ... (OGT), das Unternehmen für Molekulargenetik, erweitert seine Palette ... SureSeq myPanel™ NGS Custom FH Panels, das ein ... Hypercholesterinämie (FH) ermöglicht. Das Panel bietet eine Erkennung ... Number Variations (CNV) mit einem einzigen kleinen Panel ...
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox ... response to client demand KbioBox developed a sophisticated “3 click” gene dditing off ... accessible from KBioBox’s new website, https://www.kbiobox.com/ and powered by the ...
(Date:12/8/2016)... ... ... This CAST literature review and report looks at problems caused by the current ... in countries that are major global commodity exporters and importers, which show that asynchrony ... level presence (LLP) puts large volumes of trade worth billions of dollars at risk. ...
(Date:12/8/2016)... TAMPA, Fla. , Dec. 8, 2016 /PRNewswire/ ... biopharmaceutical company that discovers, develops and plans to ... today that its shares of common stock were approved ... stock will begin trading on the OTCQX, effective ... To qualify for the OTCQX market, companies must ...
Breaking Biology Technology:
(Date:11/29/2016)... 2016   Neurotechnology , a provider ... technologies, today released FingerCell 3.0, a software ... that run on low-power, low-memory microcontrollers. FingerCell ... than 128KB of memory, enabling it to ... limited on-board resources, such as: mobile phones, ...
(Date:11/22/2016)... 2016 According to the new market research report ... Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), ... market is expected to grow from USD 10.74 Billion in 2015 to ... 2016 and 2022. Continue Reading ... ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
Breaking Biology News(10 mins):